This site is intended for Healthcare professionals only.

New genetic tool predicts heart attack in high risk people


New genetic tool predicts heart attack in high risk people

A one-off DNA test can help in the prediction of a heart attack earlier in life in the people at high risk for the condition in their adulthood, according to a new study published in the Journal of the American College of Cardiology. 

Michael Inouye, of the Baker Heart and Diabetes Institute and the University of Cambridge, and colleagues conducted the study to construct a genomic risk score for coronary artery disease (CAD) and to estimate its potential as a screening tool for primary prevention of heart attack .

The researchers used UK Biobank data to develop and test a powerful scoring system, called a Genomic Risk Score (GRS) which can identify people who are at risk of developing coronary heart disease prematurely because of their genetics.

Genetic factors have long been known to be major contributors of someone’s risk of developing coronary heart disease – the leading cause of heart attacks. Currently to identify those at risk doctors use scores based on lifestyle and clinical conditions associated with coronary heart diseases such as cholesterol level, blood pressure, diabetes, and smoking. But these scores are imprecise, age-dependent and miss a large proportion of people who appear ‘healthy’, but will still develop the disease.

The ‘big-data’ GRS technique takes into account 1.7 million genetic variants in a person’s DNA to calculate their underlying genetic risk for coronary heart disease.

Also Read: Raised HbA1c levels increase risk of heart attack in Stable Angina

The team analyzed genomic data of nearly half a million people from the UK Biobank research project aged between 40-69 years. This included over 22,000 people who had coronary heart disease. The GRS was better at predicting someone’s risk of developing heart disease than each of the classic risk factors for coronary heart disease alone. The ability of the GRS to predict coronary heart disease was also largely independent of these known risk factors. This showed that the genes which increase the risk of coronary heart disease don’t simply work by elevating blood pressure or cholesterol, for example.

People with a genomic risk score in the top 20 percent of the population were over four times more likely to develop coronary heart disease than someone with a genomic risk score in the bottom 20 percent.

In fact, men who appeared healthy by current NHS health check standards but had a high GRS were just as likely to develop coronary heart disease as someone with a low GRS and two conventional risk factors such as high cholesterol or high blood pressure.

These findings help to explain why people with healthy lifestyles and no conventional risk factors can still be struck by a devastating heart attack.

Crucially, the GRS can be measured at any age including childhood as your DNA does not change. This means that those at high risk can be identified much earlier than is possible through current methods and can be targeted for prevention with lifestyle changes and, where necessary, medicines. The GRS is also a one-time test and with the cost of genotyping to calculate the GRS now less than £40 GBP ($50 USD), it is within the capability of many health services to provide.

Senior author Professor Sir Nilesh Samani, Professor of Cardiology at the University of Leicester and Medical Director at the British Heart Foundation said:

“At the moment we assess people for their risk of coronary heart disease in their 40’s through NHS health checks. But we know this is imprecise and also that coronary heart disease starts much earlier, several decades before symptoms develop. Therefore if we are going to do true prevention, we need to identify those at increased risk much earlier.

“This study shows that the GRS can now identify such individuals. Applying it could provide a most cost-effective way of preventing the enormous burden of coronary heart disease, by helping doctors select patients who would most benefit from interventions and avoiding unnecessary screening and treatments for those unlikely to benefit.”

“The completion of the first human genome was only 15 years ago. Today, the combination of data science and massive-scale genomic cohorts has now greatly expanded the potential of healthcare. “While genetics is not destiny for coronary heart disease, advances in genomic prediction have brought the long history of heart disease risk screening to a critical juncture, where we may now be able to predict, plan for, and possibly avoid a disease with substantial morbidity and mortality,” said Dr. Inouye.

For further reference follow the link: 10.1016/j.jacc.2018.07.079

Source: With inputs from Journal of the American College of Cardiology

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. When MCI take action on ELCTRO HOMOPATHY MD DOCTORS